End users who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
Pharmaceutical, Clinical Trials, Medical
Cannabis technology and lab Innovation providers
Consumer, OTC & Animal Health product manufacturers
Food Manufacturers, Tobacco & E-liquid
Quality Over Quantity
Director High Throughput Screening
Start-up & SME's Across Beverages, Cosmetics & Nutraceuticals etc
Heads of Testing
Analytical and Purification Scientist
Wellbeing/ Natural Remedy retailers & manufacturers
Regulatory bodies and public health
Cannabis Innovation Summit 2022
Visualising The Future
Two Days of Powerful Talks
CAIS will be bringing together some of Europe's most innovative and strategic businesses across the cannabis category such as medical, CBD - Cannabis Products & Devices, Tobacco, Cosmetics, Beverage & Nutraceuticals.
Collectively this industry is expected to be valued at €123 billion by 2028.
This thought-provoking gathering provides a unique platform for key decision-makers to network, learn and partner with some of the industries captains and solutions providers spearheading this exciting but evolving market.
Topics will include.
Drive & Shape the Future of Cannabis Policy In Europe
Medicine as Marijuana: Can We See Past the Smoke?
Opioids vs Cannabis: What is the Role of Cannabis in the Evolving Opioid Epidemic
Testing Innovation, Analytical and Cutting Edge Technology